Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Erythroblastic, Acute

Clinical trial condition

Leukemia, Erythroblastic, Acute

Explore clinical trials studying Leukemia, Erythroblastic, Acute. Study availability and eligibility vary by location and protocol.

130 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Erythroblastic, Acute trial results

Completed

Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

NCT00006122

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Innsbruck Universitaetsklinik Innsbruck, Austria

A.Z. St. Jan Bruges, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

CHU Sart-Tilman Liège, Belgium

View all 18 locations

View Trial Details

Completed

Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia

NCT00002719

Conditions: Agranulocytosis, Bone Marrow Diseases, Cytopenia, +15 more
Locations: Azienda Policlinico Umberto Primo Rome, Italy

View Trial Details

Completed

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004896

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004899

Conditions: Bone Marrow Diseases, Chronic Disease, Congenital Abnormalities, +20 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

NCT00005795

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

NCT00002945

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

NCT00003335

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00006379

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +100 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia

NCT00089050

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT00844441

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations: Oregon Health and Science University Portland, Oregon, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland

View Trial Details